KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardant Health (GH) Other Non-Current Liabilities (2018 - 2025)

Guardant Health (GH) has disclosed Other Non-Current Liabilities for 8 consecutive years, with $127.8 million as the latest value for Q4 2025.

  • Quarterly Other Non-Current Liabilities rose 37.64% to $127.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $127.8 million through Dec 2025, up 37.64% year-over-year, with the annual reading at $127.8 million for FY2025, 37.64% up from the prior year.
  • Other Non-Current Liabilities hit $127.8 million in Q4 2025 for Guardant Health, up from $94.4 million in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $127.8 million in Q4 2025 to a low of $1.7 million in Q1 2021.
  • Historically, Other Non-Current Liabilities has averaged $47.5 million across 5 years, with a median of $9.8 million in 2023.
  • Biggest five-year swings in Other Non-Current Liabilities: soared 959.39% in 2024 and later fell 4.97% in 2025.
  • Year by year, Other Non-Current Liabilities stood at $3.9 million in 2021, then soared by 133.38% to $9.2 million in 2022, then surged by 945.93% to $96.0 million in 2023, then fell by 3.3% to $92.8 million in 2024, then soared by 37.64% to $127.8 million in 2025.
  • Business Quant data shows Other Non-Current Liabilities for GH at $127.8 million in Q4 2025, $94.4 million in Q3 2025, and $91.2 million in Q2 2025.